載入...
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or expensive diagnostic tools. Therefore, a blood-based biomarker like plasma amyloid beta (Aβ) that could correlate with...
Na minha lista:
Main Authors: | , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3706955/ https://ncbi.nlm.nih.gov/pubmed/23470128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt162 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|